A randomized patient education trial investigating treatment-related distress and satisfaction with the use of an at-home gynecologic brachytherapy educational video.


Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
03 07 2023
Historique:
medline: 5 7 2023
pubmed: 30 5 2023
entrez: 29 5 2023
Statut: epublish

Résumé

Physician explanation of gynecologic brachytherapy can be overwhelming or induce patient anxiety, and may be time-constrained given clinical limitations. We report the first randomized trial of an educational video intervention in gynecologic brachytherapy on patient-reported outcomes. Between February 2020 and January 2022, 80 gynecologic cancer patients prescribed brachytherapy were randomly assigned to either standard informed consent (Arm A) or a supplemental 16 min brachytherapy educational video (https://vimeo.com/403385455/d0716e3cc8) via the internet (Arm B). Primary outcome was treatment-related distress (National Comprehensive Cancer Network (NCCN) distress scale scored 0 (no distress) to 10 (maximum distress)). Secondary outcome was patient satisfaction (summated Likert-scale scored 11-55). Surveys were administered at baseline, after first treatment, and prior to brachytherapy completion. All patients completed the prescribed brachytherapy. In Arm B, 19/40 (48%) patients and 10/40 (25%) patients' family/friends viewed the video. For patients that completed all surveys (Arm A n=29, Arm B n=28), there was no difference between arms in the sociodemographic, clinical, or treatment variables. Distress scores were low at baseline (Arm A median 4, Arm B median 4, p=0.65) and there was no detectable change in distress between arms on surveys 1 and 2 (β 0.36, p=0.67) or surveys 1 and 3 (β -1.02, p=0.29) in multivariable analysis. Satisfaction scores were high at baseline (Arm A median 54, Arm B median 54.5, p=0.64) and there was no detectable change in satisfaction between arms on surveys 1 and 2 (β 0.22, p=0.93) or surveys 1 and 3 (β 0.63, p=0.85) in multivariable analysis. Among patients randomized to an educational video tool for gynecologic brachytherapy, approximately 50% of the cohort and 25% of the cohort's family/friends used the video. Overall, patients had low distress scores and high satisfaction scores with no significant differences between the standard and video intervention arms. Further work is needed to understand factors contributing to gynecologic brachytherapy anxiety. NCT04363957.

Sections du résumé

BACKGROUND
Physician explanation of gynecologic brachytherapy can be overwhelming or induce patient anxiety, and may be time-constrained given clinical limitations. We report the first randomized trial of an educational video intervention in gynecologic brachytherapy on patient-reported outcomes.
METHODS
Between February 2020 and January 2022, 80 gynecologic cancer patients prescribed brachytherapy were randomly assigned to either standard informed consent (Arm A) or a supplemental 16 min brachytherapy educational video (https://vimeo.com/403385455/d0716e3cc8) via the internet (Arm B). Primary outcome was treatment-related distress (National Comprehensive Cancer Network (NCCN) distress scale scored 0 (no distress) to 10 (maximum distress)). Secondary outcome was patient satisfaction (summated Likert-scale scored 11-55). Surveys were administered at baseline, after first treatment, and prior to brachytherapy completion.
RESULTS
All patients completed the prescribed brachytherapy. In Arm B, 19/40 (48%) patients and 10/40 (25%) patients' family/friends viewed the video. For patients that completed all surveys (Arm A n=29, Arm B n=28), there was no difference between arms in the sociodemographic, clinical, or treatment variables. Distress scores were low at baseline (Arm A median 4, Arm B median 4, p=0.65) and there was no detectable change in distress between arms on surveys 1 and 2 (β 0.36, p=0.67) or surveys 1 and 3 (β -1.02, p=0.29) in multivariable analysis. Satisfaction scores were high at baseline (Arm A median 54, Arm B median 54.5, p=0.64) and there was no detectable change in satisfaction between arms on surveys 1 and 2 (β 0.22, p=0.93) or surveys 1 and 3 (β 0.63, p=0.85) in multivariable analysis.
CONCLUSIONS
Among patients randomized to an educational video tool for gynecologic brachytherapy, approximately 50% of the cohort and 25% of the cohort's family/friends used the video. Overall, patients had low distress scores and high satisfaction scores with no significant differences between the standard and video intervention arms. Further work is needed to understand factors contributing to gynecologic brachytherapy anxiety.
TRIAL REGISTRATION NUMBER
NCT04363957.

Identifiants

pubmed: 37247940
pii: ijgc-2023-004331
doi: 10.1136/ijgc-2023-004331
doi:

Banques de données

ClinicalTrials.gov
['NCT04363957']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1125-1131

Informations de copyright

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: DB received honorarium from Varian Medical Systems outside the submitted work. DR received honorarium from Vision RT and Radformation outside the submitted work. DS serves as a consultant for Merit Medical Inc and Varian Medical Systems outside the submitted work. JM serves as a consultant for Astra Zeneca, NRG Oncology, GOG Foundation, Varian Medical Systems, Primmune, Merck; serves as co-chair for NRG Oncology Cervix Co-Chair; serves as board member for GOG Foundation outside the submitted work. All remaining authors have declared no conflicts of interest.

Auteurs

Nikhil V Kotha (NV)

Radiation Oncology, Stanford University, Palo Alto, California, USA.

Kripa Guram (K)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Kylie Morgan (K)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Leah Deshler (L)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Derek Brown (D)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Dominique Rash (D)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Brandon Dyer (B)

Radiation Oncology, Legacy Health System, Portland, Oregon, USA.

Michael McHale (M)

Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, USA.

Catheryn Yashar (C)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Daniel Scanderbeg (D)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

John Einck (J)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.

Jyoti Mayadev (J)

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA jmayadev@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH